Noventure welcomes new partners to expand the presence of its products in new territories.

We are pleased to announce that we are expanding the international coverage of our products thanks to the recent signature of agreements with both new and loyal partners.  These new partnerships further enable us to spread our global footprint.

Soon you will be able to find our products in the following territories:

• Ukraine - Utipro® Plus (PHARM. FABRIK MONTAVIT GmbH)

• Lebanon – Aprotecol®, Gelsectan® and Xilaplus® (SPEPHAL S.A.L.)

• Romania and Greece – Gelsectan® (GALENICA, S.A.) 

• Israel - Gelsectan®, Aprotecol® and Tasectan® Duo (LAPIDOT MEDICAL).

• South Africa - Aprotecol®, Utipro® Plus (CAMOX PHARMACEUTICALS Pty Ltd.)

• Hungary – Tasectan® (ELVAPHARMA s.r.o.) 

Extending our collaboration with these valuable partners helps us to fulfill the mission to bring our innovative solutions to patients around the world.
For further information about our products click here: http://noventure.com/products